Literature DB >> 31285873

CT-based radiomics features analysis for predicting the risk of anterior mediastinal lesions.

He Sui1, Lin Liu1, Xuejia Li1, Panli Zuo2, Jingjing Cui2, Zhanhao Mo1.   

Abstract

BACKGROUND: To retrospectively validate CT-based radiomics features for predicting the risk of anterior mediastinal lesions.
METHODS: A retrospective study was performed through February 2013 to March 2018 on 298 patients who had pathologically confirmed anterior mediastinal lesions. The patients all underwent CT scans before their treatment, including 130 unenhanced computed tomography (UECT) and 168 contrast-enhanced CT (CECT) scans. The lesion areas were delineated, and a total of 1,029 radiomics features were extracted. The least absolute shrinkage and selection operator (Lasso) algorithm method was used to select the radiomics features significantly associated with discrimination of high-risk from low-risk lesions in the anterior mediastinum. Then, 8-fold and 3-fold cross-validation logistic regression (LR) models were taken as the feature selection classifiers to build the radiomics models for UECT and CECT scan respectively. The predictive performance of the radiomics features was evaluated based on the receiver operating characteristics (ROC) curve.
RESULTS: Each of the two radiomics classifiers included the optimal 12 radiomic features. In terms of the area under ROC curve, using the radiomics model in discriminating high-risk lesions from the low-risks, CECT images accounted for 74.1% with a sensitivity of 66.67% and specificity of 64.81%. Meanwhile, UECT images were 84.2% with a sensitivity of 71.43% and specificity of 74.07%.
CONCLUSIONS: The association of the two proposed CT-based radiomics features with the discrimination of high and low-risk lesions in anterior mediastinum was confirmed, and the radiomics features of the UECT scan were proven to have better prediction performance than the CECT's in risk grading.

Entities:  

Keywords:  Radiomics; anterior mediastinum; contrast-enhanced computed tomography (CECT); histologic grade; unenhanced computed tomography (UECT)

Year:  2019        PMID: 31285873      PMCID: PMC6588768          DOI: 10.21037/jtd.2019.05.32

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  24 in total

Review 1.  Approaching the patient with an anterior mediastinal mass: a guide for radiologists.

Authors:  Brett W Carter; Meinoshin Okumura; Frank C Detterbeck; Edith M Marom
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

Review 2.  Approaching the patient with an anterior mediastinal mass: a guide for clinicians.

Authors:  Brett W Carter; Edith M Marom; Frank C Detterbeck
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

Review 3.  Prediction of thymoma histology and stage by radiographic criteria.

Authors:  Masahiro Yanagawa; Noriyuki Tomiyama
Journal:  Thorac Surg Clin       Date:  2011-02       Impact factor: 1.750

Review 4.  The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes.

Authors:  Alexander Marx; John K C Chan; Jean-Michel Coindre; Frank Detterbeck; Nicolas Girard; Nancy L Harris; Elaine S Jaffe; Michael O Kurrer; Edith M Marom; Andre L Moreira; Kiyoshi Mukai; Attilio Orazi; Philipp Ströbel
Journal:  J Thorac Oncol       Date:  2015-10       Impact factor: 15.609

Review 5.  Histologic classification of thymoma: the World Health Organization and beyond.

Authors:  Saul Suster; Cesar A Moran
Journal:  Hematol Oncol Clin North Am       Date:  2008-06       Impact factor: 3.722

Review 6.  Radiomics: the process and the challenges.

Authors:  Virendra Kumar; Yuhua Gu; Satrajit Basu; Anders Berglund; Steven A Eschrich; Matthew B Schabath; Kenneth Forster; Hugo J W L Aerts; Andre Dekker; David Fenstermacher; Dmitry B Goldgof; Lawrence O Hall; Philippe Lambin; Yoganand Balagurunathan; Robert A Gatenby; Robert J Gillies
Journal:  Magn Reson Imaging       Date:  2012-08-13       Impact factor: 2.546

Review 7.  Radiomics: extracting more information from medical images using advanced feature analysis.

Authors:  Philippe Lambin; Emmanuel Rios-Velazquez; Ralph Leijenaar; Sara Carvalho; Ruud G P M van Stiphout; Patrick Granton; Catharina M L Zegers; Robert Gillies; Ronald Boellard; André Dekker; Hugo J W L Aerts
Journal:  Eur J Cancer       Date:  2012-01-16       Impact factor: 9.162

8.  Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis.

Authors:  Philipp Ströbel; Andrea Bauer; Bernhard Puppe; Til Kraushaar; Axel Krein; Klaus Toyka; Ralf Gold; Michael Semik; Reinhard Kiefer; Wilfred Nix; Berthold Schalke; Hans Konrad Müller-Hermelink; Alexander Marx
Journal:  J Clin Oncol       Date:  2004-04-15       Impact factor: 44.544

9.  New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China.

Authors:  Gang Chen; Alexander Marx; Wen-Hu Chen; Jiang Yong; Bernhard Puppe; Philipp Stroebel; Hans Konrad Mueller-Hermelink
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

10.  Diffusion-weighted MR imaging in thymic epithelial tumors: correlation with World Health Organization classification and clinical staging.

Authors:  Ahmed Abdel Khalek Abdel Razek; Mohamed Khairy; Nadia Nada
Journal:  Radiology       Date:  2014-05-31       Impact factor: 11.105

View more
  9 in total

1.  Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.

Authors:  Yu Zhang; Yifeng Zhu; Kai Zhang; Yajie Liu; Jingjing Cui; Juan Tao; Yingzi Wang; Shaowu Wang
Journal:  Radiol Med       Date:  2019-11-06       Impact factor: 3.469

2.  CT-based radiomics analysis for differentiation between thymoma and thymic carcinoma.

Authors:  Ryosuke Ohira; Masahiro Yanagawa; Yuki Suzuki; Akinori Hata; Tomo Miyata; Noriko Kikuchi; Yuriko Yoshida; Kazuki Yamagata; Shuhei Doi; Keisuke Ninomiya; Noriyuki Tomiyama
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

3.  Hepatic Alveolar Echinococcosis: Predictive Biological Activity Based on Radiomics of MRI.

Authors:  Bo Ren; Jian Wang; Zhoulin Miao; Yuwei Xia; Wenya Liu; Tieliang Zhang; Aierken Aikebaier
Journal:  Biomed Res Int       Date:  2021-04-09       Impact factor: 3.411

4.  Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging.

Authors:  Xue Sha; Guanzhong Gong; Qingtao Qiu; Jinghao Duan; Dengwang Li; Yong Yin
Journal:  BMC Med Imaging       Date:  2020-02-05       Impact factor: 1.930

5.  Anterior Mediastinal Lesion Segmentation Based on Two-Stage 3D ResUNet With Attention Gates and Lung Segmentation.

Authors:  Su Huang; Xiaowei Han; Jingfan Fan; Jing Chen; Lei Du; Wenwen Gao; Bing Liu; Yue Chen; Xiuxiu Liu; Yige Wang; Danni Ai; Guolin Ma; Jian Yang
Journal:  Front Oncol       Date:  2021-02-08       Impact factor: 6.244

6.  Contrast-enhanced CT-based radiomics model for differentiating risk subgroups of thymic epithelial tumors.

Authors:  Chunhai Yu; Ting Li; Xiaotang Yang; Ruiping Zhang; Lei Xin; Zhikai Zhao; Jingjing Cui
Journal:  BMC Med Imaging       Date:  2022-03-06       Impact factor: 1.930

7.  Prediction Models for Prognosis of Femoral Neck-Fracture Patients 6 Months after Total Hip Arthroplasty.

Authors:  Xiaofeng Zheng; Cong Xiao; Zhuocheng Xie; Lijuan Liu; Yinhua Chen
Journal:  Int J Gen Med       Date:  2022-04-21

8.  Development and Validation of a CT-Based Radiomics Nomogram in Patients With Anterior Mediastinal Mass: Individualized Options for Preoperative Patients.

Authors:  Zhou Zhou; Yanjuan Qu; Yurong Zhou; Binchen Wang; Weidong Hu; Yiyuan Cao
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

9.  Can computed tomography-based radiomics potentially discriminate between anterior mediastinal cysts and type B1 and B2 thymomas?

Authors:  Lulu Liu; Fangxiao Lu; Peipei Pang; Guoliang Shao
Journal:  Biomed Eng Online       Date:  2020-11-27       Impact factor: 2.819

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.